GlassScriptPhysician profile
Casey R Antholz
NPI 1558655308
$3,491.71
in general payments reported to CMS, 2019-2025
16 companies · $559 in 2025
The $559 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,937 · 2020: $16.48 · 2021: $144 · 2022: $296 · 2023: $280 · 2024: $259 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,955.03 | 2019-2025 | Pico |
| Zimmer Biomet Holdings, INC. | $509.39 | 2019-2025 | Rosa, Persona |
| Stryker Corporation | $338.57 | 2019-2025 | Pangea, Conextions Tr Tendon Repair System-Implant Mechanism, Knifelight |
| Cumberland Pharmaceuticals, INC. | $110.46 | 2022-2025 | Caldolor |
| Ethicon US, LLC | $95.31 | 2022-2024 | Monocryl, Stratafix, Enseal X1 |
| Ferring Pharmaceuticals INC. | $80.17 | 2022-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $79.17 | 2023-2025 | Zilretta, Exparel, Iovera |
| Endo Pharmaceuticals INC. | $72.51 | 2022-2023 | Xiaflex |
| Depuy Synthes Sales INC. | $57.92 | 2022-2024 | Orthovisc, Monovisc |
| Vertex Pharmaceuticals Incorporated | $50.52 | 2025 | |
| Endo USA, INC. | $34.18 | 2024-2025 | Xiaflex |
| Innovation Technologies INC | $33.67 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $29.49 | 2023 | |
| Amniox Medical, INC. | $16.48 | 2020 | |
| Molnlycke Health Care US, LLC | $15.93 | 2025 | Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Antholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.